CDNA: CareDx, Inc.
About
CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.
Key Details
Market Cap
$1.18B
P/E Ratio
-8.17
1Y Stock Return
132.21%
1Y Revenue Growth
5.26%
Dividend Yield
0.00%
Price to Book
4.3
Strategies that include CDNA
Stock's related to CDNA
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| MTD | 47.66% | $24.49B | +6.92% | 0.00% |
| NVAX | 46.05% | $1.28B | +49.53% | 0.00% |
| TECH | 42.89% | $10.55B | +4.49% | 0.48% |
| ITOS | 41.58% | $288.62M | -19.06% | 0.00% |
| SG | 40.24% | $4.38B | +299.68% | 0.00% |
| ARR | 39.60% | $1.05B | +8.10% | 16.27% |
| OPEN | 39.35% | $1.14B | -31.62% | 0.00% |
| LH | 38.61% | $19.76B | +11.24% | 0.91% |
| PGEN | 38.46% | $228.91M | -28.00% | 0.00% |
| GRAL | 38.05% | $459.22M | -13.00% | 0.00% |
| ETD | 37.72% | $740.01M | +7.77% | 5.25% |
| CWEN | 37.64% | $3.26B | +22.27% | 5.84% |
| ORGO | 37.59% | $540.91M | +59.38% | 0.00% |
| CPRX | 37.35% | $2.55B | +55.68% | 0.00% |
| BLFS | 37.13% | $1.04B | +64.64% | 0.00% |
| KW | 36.88% | $1.52B | -2.38% | 6.53% |
| CLNE | 36.84% | $589.93M | -23.92% | 0.00% |
| ADPT | 36.63% | $661.15M | +6.16% | 0.00% |
| RMAX | 36.61% | $215.33M | +23.09% | 0.00% |
| STE | 36.56% | $20.93B | +5.37% | 1.28% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| AGX | -0.01% | $2.01B | +224.91% | 0.85% |
| TPST | 0.01% | $37.75M | -77.59% | 0.00% |
| LPLA | -0.02% | $23.55B | +38.13% | 0.38% |
| BPT | 0.06% | $24.61M | -66.18% | 0.00% |
| HIHO | -0.08% | $8.63M | 0.00% | 6.12% |
| AVD | -0.08% | $182.80M | -32.45% | 1.42% |
| LFVN | -0.09% | $169.84M | +130.61% | 1.10% |
| NOC | 0.10% | $71.54B | +4.23% | 1.60% |
| TH | 0.14% | $839.02M | -24.49% | 0.00% |
| RBRK | 0.17% | $8.03B | +38.16% | 0.00% |
| QURE | -0.20% | $283.68M | -13.52% | 0.00% |
| TRVG | 0.25% | $37.05M | -37.92% | 0.00% |
| LMT | 0.27% | $126.40B | +18.99% | 2.36% |
| MANU | 0.27% | $2.88B | -9.41% | 0.00% |
| NLOP | -0.29% | $458.04M | +94.60% | 0.00% |
| KLG | 0.30% | $1.48B | +45.15% | 3.71% |
| ALAB | -0.32% | $15.10B | +164.39% | 0.00% |
| LPTH | 0.35% | $62.27M | +33.05% | 0.00% |
| LQDA | 0.39% | $859.91M | +53.94% | 0.00% |
| CPSH | 0.43% | $20.70M | -40.13% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| OKLO | -13.88% | $2.66B | +111.04% | 0.00% |
| MCK | -11.90% | $78.15B | +35.51% | 0.42% |
| RNR | -11.10% | $13.74B | +23.09% | 0.58% |
| MGNX | -10.70% | $218.42M | -53.04% | 0.00% |
| FROG | -10.39% | $3.34B | +11.67% | 0.00% |
| PULM | -10.26% | $19.83M | +202.98% | 0.00% |
| QTTB | -9.56% | $354.34M | +188.64% | 0.00% |
| AKAM | -9.45% | $13.12B | -22.78% | 0.00% |
| MNR | -9.09% | $1.66B | -10.71% | 15.90% |
| FATBB | -9.01% | $81.94M | -12.91% | 11.69% |
| TRV | -7.81% | $58.86B | +48.10% | 1.59% |
| COLL | -7.69% | $959.44M | +16.71% | 0.00% |
| FAT | -7.56% | $89.30M | -11.53% | 10.73% |
| MSDL | -7.32% | $1.83B | +0.66% | 7.26% |
| TCTM | -7.19% | $8.10M | -42.99% | 0.00% |
| YPF | -6.78% | $13.98B | +139.72% | 0.00% |
| NTZ | -6.77% | $47.64M | -30.94% | 0.00% |
| JRVR | -6.57% | $168.34M | -52.25% | 4.52% |
| EG | -6.18% | $15.92B | -8.98% | 2.02% |
| FLUX | -5.91% | $37.37M | -36.18% | 0.00% |
ETF's related to CDNA
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| ARKG | 53.23% | $1.13B | 0.75% |
| GNOM | 51.24% | $70.59M | 0.5% |
| FBT | 47.33% | $1.11B | 0.56% |
| PBE | 45.76% | $258.53M | 0.58% |
| XHE | 44.89% | $213.41M | 0.35% |
| XBI | 44.84% | $6.58B | 0.35% |
| IBB | 44.59% | $6.66B | 0.45% |
| EDOC | 44.32% | $40.86M | 0.68% |
| RSPH | 43.40% | $885.96M | 0.4% |
| IJR | 42.74% | $90.05B | 0.06% |
| VIOO | 42.66% | $3.12B | 0.1% |
| FIW | 42.46% | $1.86B | 0.53% |
| IYR | 42.00% | $4.56B | 0.39% |
| FXH | 41.94% | $1.15B | 0.62% |
| PID | 41.87% | $838.56M | 0.53% |
| VXF | 41.34% | $21.54B | 0.06% |
| KBWD | 41.25% | $397.36M | 2.02% |
| PRNT | 40.59% | $95.35M | 0.66% |
| MDIV | 40.38% | $451.99M | 0.68% |
| PRFZ | 40.34% | $2.65B | 0.39% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BSCO | 0.20% | $2.35B | 0.1% |
| THTA | -0.59% | $32.20M | 0.49% |
| COMT | 0.71% | $829.06M | 0.48% |
| TAIL | -0.84% | $67.98M | 0.59% |
| GSG | 1.05% | $914.42M | 0.75% |
| HIGH | -1.34% | $302.78M | 0.51% |
| DBO | -1.36% | $217.57M | 0.77% |
| AGZD | -1.37% | $142.76M | 0.23% |
| IBHD | 1.43% | $327.80M | 0.35% |
| FLRN | -1.55% | $2.33B | 0.15% |
| KRBN | 1.72% | $242.47M | 0.85% |
| DUSB | 1.99% | $797.63M | 0.15% |
| DBE | -2.10% | $50.13M | 0.77% |
| USCI | 2.55% | $185.47M | 1.07% |
| WEAT | 2.61% | $120.27M | 0.28% |
| CORN | 2.72% | $61.12M | 0.2% |
| CANE | 2.98% | $17.72M | 0.29% |
| KCCA | 3.34% | $220.51M | 0.87% |
| MINT | 3.43% | $11.62B | 0.35% |
| UNG | 3.51% | $908.80M | 1.06% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -33.75% | $388.04M | 1.43% |
| USDU | -30.27% | $201.97M | 0.5% |
| UUP | -28.25% | $309.25M | 0.77% |
| VIXY | -14.21% | $195.31M | 0.85% |
| EQLS | -12.98% | $76.08M | 1% |
| KMLM | -11.24% | $353.87M | 0.9% |
| CTA | -9.47% | $350.27M | 0.78% |
| DBMF | -4.61% | $1.02B | 0.85% |
| DBA | -4.26% | $755.88M | 0.93% |
| DBE | -2.10% | $50.13M | 0.77% |
| FLRN | -1.55% | $2.33B | 0.15% |
| AGZD | -1.37% | $142.76M | 0.23% |
| DBO | -1.36% | $217.57M | 0.77% |
| HIGH | -1.34% | $302.78M | 0.51% |
| TAIL | -0.84% | $67.98M | 0.59% |
| THTA | -0.59% | $32.20M | 0.49% |
| BSCO | 0.20% | $2.35B | 0.1% |
| COMT | 0.71% | $829.06M | 0.48% |
| GSG | 1.05% | $914.42M | 0.75% |
| IBHD | 1.43% | $327.80M | 0.35% |
News
Yahoo
The heavy selling pressure might have exhausted for CareDx (CDNA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Yahoo
Here is how CareDx (CDNA) and Doximity (DOCS) have performed compared to their sector so far this year.
Yahoo
The DOJ suggests that UNH's acquisitions reflect a strategy of buying competitors rather than competing directly, potentially giving it control over multiple markets.
Yahoo
CI reaffirms its 2024 outlook, projecting full-year adjusted EPS to be a minimum of $28.40.
Yahoo
BRISBANE, Calif., November 12, 2024--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced the company will participate in the following investor conferences.
Yahoo
Baron Funds, an investment management company, released its “Baron Discovery Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. In the third quarter, the fund appreciated 13.55% (Institutional Shares), outperforming the 8.41% return for the Russell 2000 Growth Index. Year-to-date, the fund returned 9.50% compared to the index’s 13.22% […]
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.